InflaRx NV
NASDAQ:IFRX
InflaRx NV
NASDAQ:IFRX
Price:
1.295 USD
-6.16%
Market Closed
Updated:
May 7, 2024
InflaRx NV
Operating Income
|
InflaRx NV
Operating Income Peer Comparison
Comparables:
BNTX
MOR
IMTX
BIO
FYB
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
InflaRx NV
NASDAQ:IFRX
|
Operating Income
-€44.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Operating Income
€908m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MorphoSys AG
XETRA:MOR
|
Operating Income
-€232.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
Immatics NV
NASDAQ:IMTX
|
Operating Income
-€101.7m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Operating Income
€120.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
57%
|
CAGR 10-Years
8%
|
|
|
Formycon AG
XETRA:FYB
|
Operating Income
-€17.7m
|
CAGR 3-Years
-100%
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
See Also
What is InflaRx NV's Operating Income?
Operating Income
-44.9m
EUR
-44.9m
EUR
Based on the financial report for Dec 31, 2023, InflaRx NV's Operating Income amounts to -44.9m EUR.
What is InflaRx NV's Operating Income growth rate?
Operating Income CAGR 5Y
-4%
-4%
Over the last year, the Operating Income growth was -39%. The average annual Operating Income growth rates for InflaRx NV have been -10% over the past three years , -4% over the past five years .
You don't have any saved screeners yet
